Scholarly article on topic 'The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases'

The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases Academic research paper on "Veterinary science"

0
0
Share paper
Academic journal
Pediatr Rheumatol
OECD Field of science
Keywords
{""}

Academic research paper on topic "The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases"

Klochkova et al. Pediatric Rheumatology 2011, 9(Suppl 1):P290

http://www.ped-rheum.eom/content/9/S1/P290 * % PEDIATRIC

RHEUMATOLOGY

POSTER PRESENTATION Open Access

The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases

Olga Klochkova*, Leila Namazova-Baranova, Ekaterina Alekseeva, Olga Kozhevnikova

From 18th Pediatric Rheumatology European Society (PReS) Congress Bruges, Belgium. 14-18 September 2011

Background

Total antinuclear antibodies (ANA) are widely detected in pediatric rheumatology, while the data about specific ANA are few and controversial.

To evaluate the levels of ds-DNA, Sm, anti-Ro, anti-Jo1, Scl-70 antibodies in serum of children with connective tissue diseases (CTDs). To look for correlations between clinical features of the CTDs, age and gender of children and specific ANA concentrations.

Methods

We observed 187 children from 2 to 18 years (median 13 years, 25%o - 9 years, 75%o - 15 years); 70 (37,4%) boys, 117 (62,6%) - girls with systemic lupus erythema-tosis (SLE), juvenile rheumatoid arthritis (JRA), spondy-loarthritis (SA), scleroderma (systemic/localized), dermatomyosites and mixed CTD (MCTD). All patients undergo common rheumatologic examination. Specific ANA were measured with Elia method on ImmunoCAP 250 (Phadia).

Results

Only girls with CTDs had positive specific ANA. There were no significant differences between the ages of children with positive and negative results and with different positive antibodies. Duration of the disease and concentration of antibodies didn't correlate. Children with positive results had severer forms of CTDs, but there were also 4 patients with active SLE and negative results of measured antibodies. Anti-Ro were detected in the «above» concentrations in 7 cases (all with SLE) and anti-Jo-1 - in all positive cases. 7 children with SLE had combination of positive ds-DNA and Sm or ds-DNA and anti-Ro. (Table 1)

Conclusion

Ds-DNA, Sm, anti-Ro, anti-Jo1 were found predominantly in girls with SLE. The levels of antibodies didn't correlate with age and duration of the disease. Evaluation of Scl-70 was not indicative for systemic or localized scleroderma. Further observations are necessary to evaluate the prognostic value of measured specific ANA in these children.

Table 1

ANA Number of positive results Negative results (median concentration; 25%o; 75%o)

dsDNA 19 (10,1%) (17 SLE, 1 JRA, 1 scleroderma) 1 (0,4;2) (lU/ml)

Sm 4 (2%) (4 SLE) 0,1 (0;0,3) (U/ml)

anti-Ro 13 (7%) (10 SLE, 2 MCTD, 1 systemic scleroderma) 0,1 (0;0,3) (U/ml)

anti-Jol 2 (1%) (2 MCTD) 0 (0; 0,1) (U/ml)

Scl-70 0 0 (0;0,1) (U/ml)

Scientific Centre of Child Health (RAMS), Moscow, Russian Federation

© 2011 Klochkova et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative CGntfäl Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Klochkova et al. Pediatric Rheumatology 2011, 9(Suppl 1):P290 Page 2 of 2

http://www.ped-rheum.eom/content/9/S1/P290

Published: 14 September 2011

doi:10.1186/1546-0096-9-S1 -P290

Cite this article as: Klochkova et al.: The analysis of specific antinuclear antibodies concentrations in children with connective tissue diseases.

Pediatric Rheumatology 2011 9(Suppl 1):P290.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at fpntral

www.biomedcentral.com/submit v_enudi